A Study of Maribavir Pediatric Formulation in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 25, 2023

Primary Completion Date

August 25, 2023

Study Completion Date

September 1, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

Maribavir Commercial Tablet Formulation

Maribavir commercial tablet.

DRUG

Maribavir Pediatric Powder-for-oral Suspension Formulation

Maribavir pediatric powder-for-oral suspension.

DRUG

Rabeprazole

Rabeprazole tablet.

Trial Locations (1)

85283

Celerion, Tempe

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT05918822 - A Study of Maribavir Pediatric Formulation in Healthy Adult Participants | Biotech Hunter | Biotech Hunter